ARPC2: A Potential Drug Target and Biomarker (G10109)

Target Name: ARPC2

NCBI ID: G10109

ARPC2

ARPC2: A Potential Drug Target and Biomarker

Autophagy-regulated protein (ARPC2) is a protein that plays a crucial role in the regulation of cell processes, including those related to autophagy, a process by which cells break down and recycle their own damaged or unnecessary components. ARPC2 has also been shown to be involved in a variety of cellular processes, including cell signaling, migration, and the development of cancer. As a result, ARPC2 has potential as a drug target and biomarker.

The Role of ARPC2 in Cellular Processes

ARPC2 is involved in a number of cellular processes that are essential for cell survival and function. One of its main functions is to regulate autophagy, a process by which cells break down and recycle their own damaged or unnecessary components. During autophagy, ARPC2 helps to transport damaged or unnecessary proteins to the endoplasmic reticulum, where they can be degraded and eliminated.

In addition to its role in autophagy, ARPC2 is also involved in a variety of other cellular processes. For example, it has been shown to be involved in cell signaling, specifically in the regulation of the TGF-β pathway. TGF-β is a signaling pathway that plays a role in the development and maintenance of tissues, including bones, skin, and organs. ARPC2 has been shown to regulate the activity of TGF-β by interacting with its downstream transcription factor, SMAD2.

ARPC2 is also involved in the regulation of cell migration. When cells are faced with a change in their environment or require to move to a new location, ARPC2 helps to regulate the movement of those cells. This is accomplished through the regulation of the vimentin protein, which is a component of the cytoskeleton.

Potential Therapeutic Applications

The potential therapeutic applications for ARPC2 are vast. Given its involvement in a variety of cellular processes, it is a likely candidate for a variety of diseases. For example, ARPC2 has been shown to be involved in the development and progression of various types of cancer, including breast, ovarian, and prostate cancer. As a result, ARPC2 may be a useful target for cancer therapies.

In addition to its potential as a cancer therapeutic, ARPC2 may also be a useful biomarker for certain types of cancer. For example, ARPC2 has been shown to be elevated in the blood and urine of patients with breast cancer, which may indicate that the cancer has spread to those areas. Additionally, ARPC2 has been shown to be elevated in the urine of patients with prostate cancer, which may indicate that the cancer has spread to those areas.

ARPC2 as a Drug Target

Given its involvement in a variety of cellular processes, ARPC2 makes it an attractive candidate for drug targeting. One potential approach to targeting ARPC2 is to use small molecules that can inhibit its activity. For example, small molecules that inhibit the activity of ARPC2's downstream target, SMAD2, could be used to prevent the recruitment of ARPC2 to the endoplasmic reticulum and thus inhibit its ability to regulate autophagy.

Another potential approach to targeting ARPC2 is to use antibodies that specifically recognize and target ARPC2 itself. This approach has the advantage of being able to selectively target ARPC2 without affecting other cellular processes. antibodies that recognize and target ARPC2 could be used to prevent the movement of ARPC2 to the endoplasmic reticulum, which would inhibit its ability to regulate autophagy.

Conclusion

ARPC2 is a protein that plays a

Protein Name: Actin Related Protein 2/3 Complex Subunit 2

Functions: Actin-binding component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). Seems to contact the mother actin filament (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947)

The "ARPC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARPC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets